"Epitomee Medical (TASE: EPIT), the Israel-based bio-medical company, announced this morning the completion of its Initial Public Offering on the Tel Aviv Stock Exchange: The company raised $51 million from institutional investors, includi...
HIRSCHL NETWORK - Research and Strategic Consultancy on EU&DACH For Non-European Organizations, News on Start-ups&Business of Israel and Founder of Disruptive Philosophy Network
View all posts by Naftali Hirschl, Ph.D